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INTERPRETATIVE SUMMARY 1 
Concomitant LPS induced transfer of blood derived components including 2 
immunoglobulins into milk.  By Lehmann et al. 3 
By the use of animals with manipulated blood BHBA concentration this study confirms the 4 
expected blood origin of a number of factors that increase in milk during the early phase of 5 
LPS-induced mastitis and describes the time course of their increase relative to that of somatic 6 
cell count. The milk concentration of L-lactate, BHBA, lactate dehydrogenase, IgG1, and IgG2 7 
increased concomitantly in the milk of LPS-challenged quarters suggesting their blood origin. 8 
Many of these blood components leak into milk but are not necessarily involved in mammary 9 
immune defence. 10 
 11 
 12 
 13 
BLOOD COMPONENTS IN MILK DURING MASTITIS  14 
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ABSTRACT 36 
During a mammary immune response the integrity of the blood milk barrier is negatively 37 
affected and becomes leaky. The aim of the present study was to demonstrate the blood 38 
origin, and to investigate changes in the concentration, of various constituents including 39 
immunoglobulins in blood and milk during the early phase of a lipopolysaccharide (LPS) 40 
induced mastitis. Five lactating dairy cows received continuous β-hydroxybutyric acid 41 
(BHBA) clamp infusions to maintain elevated BHBA blood concentrations (1.5 - 2.0 42 
mmol/L) from 48 h before and 8h after LPS administration. One udder quarter was infused 43 
with 200 μg of E. coli LPS. A second quarter served as control. Milk and blood samples were 44 
taken hourly for 8h post-challenge (PC). The somatic cell count (SCC) in LPS challenged 45 
quarters was increased from 4 h PC until the end of the experiment compared to control 46 
quarters. In LPS challenged quarters, L-lactate, BHBA, LDH, Immunoglobulin (Ig) G1, and 47 
IgG2 were increased at 3 h PC and remained elevated until the end of experiment (8 h PC) as 48 
compared to control quarters. In addition, the optical density (OD) values in milk in a non-49 
quantitative ELISA for antibodies directed against bluetongue virus (used as a measure of 50 
non-specific antibody transfer; all animals were vaccinated) increased and thus indicates an 51 
increase of these antibodies in response to LPS treatment. L-lactate concentration also 52 
increased in blood 2 h PC and in the milk of control quarters during the experiment from 3h 53 
PC. A second experiment was conducted in vitro to investigate a possible contribution from 54 
destructed milk cells on L-lactate and activity of LDH in milk. Aliquots of milk samples 55 
(n=8) were frozen (-20 °C) or disrupted with ultrasound, respectively. Freeze thawing and 56 
ultrasound treatment increased LDH in milk samples, but had no effect on L-lactate 57 
concentrations. Results suggest that intramammary infusion of LPS induces a systemic 58 
response as evidenced by an elevation of blood L-lactate. The concomitant changes of all 59 
investigated components suggest that they were blood-derived.  However, the increase of 60 
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blood components in the milk is not necessarily supportive of the mammary immune system, 61 
and likely a side effect of reduced blood-milk barrier integrity.  62 
 63 
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INTRODUCTION 67 
In the bovine mammary gland, invading pathogens induce an immune response by stimulating 68 
the innate immune system. It is generally accepted that the main effectors of the mammary 69 
immune defense against mastitis-causing bacteria are blood derived polymorphonuclear 70 
neutrophils (PMN) (Burton and Erskine, 2003). Their infiltration into the mammary gland 71 
and their accumulation in milk is measured as an increase of the milk somatic cell count 72 
(SCC), which is widely used as a measure of hygienic milk quality (Harmon, 1994).  73 
During the early acute stage of mammary inflammation a leakage of blood constituents occurs 74 
because of an alteration in the blood milk barrier (Burton and Erskine, 2003). In addition to 75 
SCC, the concentrations of a number of other components change in milk in response to 76 
inflammation of the mammary gland, not all of which contribute to host-defence. 77 
Milk L-lactate (hereafter referred to as lactate) and the enzyme, lactate dehydrogenase (LDH) 78 
increase in milk during intramammary infection and have been considered indicators of 79 
mastitis even though the immunological contribution of these factors is not known (Davis et 80 
al., 2004; Chagunda et al., 2006). Immunoglobulin (Ig) G is the major immunoglobulin in 81 
ruminant milk (Butler, 1983) and consists of two subclasses, IgG1 & IgG2. IgG1 is the 82 
predominant antibody type in milk from healthy quarters because of an active, selective IgG1 83 
transport across the blood milk barrier likely mediated by the FcRn receptor system (Baker et 84 
al., 2009). In mastitic milk IgG2 increases in concentration (Caffin and Poutrel, 1988) and 85 
plays a critical role in mammary immune defense against mastitis pathogens (Burton and 86 
Erskine, 2003). However, antibodies which are not directed against mastitis-causing 87 
pathogens are also nonspecifically transferred into the mammary gland and can be found in 88 
the milk of healthy udders, e.g. antibodies against the bovine viral diarrhea (BVD) virus or 89 
those against bluetongue virus (Kramps et al., 1999; Kramps et al., 2008). After the 90 
bluetongue disease outbreak in Northern Europe in 2006, Swiss cows were vaccinated against 91 
the bluetongue virus serotype 8 (BTV-8) between 2008 and 2010.  92 
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Another blood constituent without any obvious benefit for immune defense in the mammary 93 
gland is the ketone body, β-hydroxybutyrate (BHBA), which is produced by the liver. A 94 
significant correlation of 0.66 between BHBA in blood and milk was described by Enjalbert 95 
et al. (2001), however information on its possible role in mammary gland health was not 96 
provided. Intramammary administration of lipopolysaccharide (LPS) from Escherichia coli, a 97 
common mastitis pathogen, is a well established method to experimentally induce mastitis 98 
under defined conditions for studying the immune response of the mammary gland (Schmitz 99 
et al., 2004; Baumert et al., 2009; Wellnitz et al., 2011). In these studies LPS from different E. 100 
coli strains were shown to require different concentrations in order to induce comparable 101 
immune responses of the mammary gland. This effect is, besides differences in individual 102 
responsiveness, due to variations in the fine structure of LPS (Rietschel et al., 1994).  103 
The objective of the present study was to document changes in milk SCC and lactate, BHBA, 104 
LDH, IgG1, and IgG2 in milk and to contrast these changes to those in blood during the first 105 
hours of LPS induced mastitis. We hypothesized that the increase of lactate, along with that of 106 
other components that are expected to originate from blood, is a result of loss of the integrity 107 
of the blood milk barrier. An additional experiment was performed to establish the origin of 108 
lactate in milk. 109 
 110 
 111 
MATERIALS AND METHODS 112 
Experiment 1: LPS induced mastitis  113 
Animals and management 114 
Five mid-lactating dairy cows (Holstein) in their 3rd to 4th lactation were used in these studies. 115 
While maintained in a tie stall, foremilk samples were taken from each quarter approximately 116 
three weeks before, one week before and immediately before the start of the experiment to 117 
verify a constantly low SCC (<150,000 cells/mL). A DeLaval cell counter, (DCC) (DeLaval, 118 
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Tumba, Sweden), was used to measure SCC. All cows had been immunized against the 119 
bluetongue virus serotype 8 (Bovilis® BTV8, Intervet) approximately one year before the 120 
experiment as a part of a national vaccination campaign.  121 
 122 
Experimental design 123 
DL-Beta-hydroxybutyric acid solution (2.14M; Sigma-Aldrich, H6501) was infused 48 h 124 
before and during the LPS challenge to induce a hyperketonemia (1.5 to 2.0 mmol/L of 125 
BHBA in the plasma) throughout the experiment as described by Zarrin et al. (2011). Two 126 
intravenous catheters (Cavafix® Certo® Splittocan®, B. Braun Melsungen AG, Germany) 127 
inserted one in each jugular vein were used to infuse BHBA and to take blood samples, 128 
respectively.  129 
On the day of challenge and after the morning milking, cows were intra-mammarily infused 130 
with 200 μg E. coli LPS into the left front quarter (LPS from E .coli serotype O26:B6, Sigma 131 
Aldrich, Buchs, Switzerland) diluted in 10 mL of sterile saline solution (9 g/L). The right 132 
front quarter was used as a control and treated with 10 mL of the saline solution. Milk 133 
samples (~20mls) were hand collected for an immediate SCC measurement that continued 134 
hourly for 8 hours post-challenge from the experimental quarters after discarding the first 135 
three squirts of milk. Milk samples were frozen at -20 °C for later analyses. Skim milk was 136 
prepared by centrifugation at 4,000 x g for 15 min and milk serum was prepared by 137 
centrifugation of the skim milk at 14,000 x g for 30 min.  138 
Blood samples were collected at times coinciding with milk sample collection. Blood was 139 
collected into tubes containing FE Sodium Fluoride/tri-potassium-EDTA (Greiner Bio-One, 140 
Kremsmünster, Austria) as anticoagulant. Tubes were stored briefly on wet ice and then 141 
centrifuged for 20 minutes at 3,000 x g. Plasma was collected and frozen at -20 °C until 142 
analyses. 143 
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LDH activity, lactate concentration, and BHBA concentration were measured in milk serum 144 
and blood plasma using the test kits LDH IFCC (Axon Lab AG, Baden, Switzerland), Lactate 145 
PAP (bioMérieux, Marcy l`Etoile, France) and Ranbut (Randox Laboratories, UK), 146 
respectively, with an automated analyzer (COBAS MIRA, Roche Diagnostics, Switzerland) 147 
according to the manufacturer’s instructions.  148 
The IgG1 and IgG2 concentrations in skim milk and blood plasma were measured using 149 
bovine IgG1 and IgG2 ELISA quantitation kits (Bethyl Laboratories, Montgomery, USA) 150 
according to the manufacturer`s instructions with the following slight modifications.  151 
After coating of plates overnight with anti-bovine IgG1/ IgG2 the plates were washed using an 152 
automatic washing system (microplate washer Columbus Pro, Tecan, Männedorf, 153 
Switzerland) and subsequently blocked with 150 µl/well of 5 % fish skin gelatin (Sigma 154 
Aldrich, Buchs, Switzerland) in distilled water for 60 min at room temperature. After 155 
washing, 100 µl of skim milk diluted in washing buffer (1:100 for IgG2 and 1:1000 for IgG1) 156 
or blood plasma samples were added to each well. On the plate, the samples were diluted in 157 
three serial 1:2 dilutions using a multichannel pipette. One control sample was added to each 158 
plate and was used for the calculation of coefficients of variations that reached 10 and 20% 159 
within, and between assays, respectively. Plates were incubated for 60 min at room 160 
temperature and subsequently washed as described above. Sheep anti-bovine IgG1/ IgG2 HRP 161 
conjugated antibody were diluted 1:15,000 and 1:10,000, respectively in wash buffer and 100 162 
µl of this solution was added to each well. The concentrations of IgG1 and IgG2 were 163 
calculated by extrapolating from a standard curve generated by a Thermomax microplate 164 
reader (Molecular Devices, Basel, Switzerland). 165 
The ELISA test kit INGEZIM BTV-MILK 12.BTV.K1 (Inmunologia y Genetica Aplicada, 166 
S.A., Madrid, Spain) was used to determine bluetongue antibodies in skim milk according to 167 
manufacturer`s instructions. OD values were measured at 450 nm by using the Thermovax 168 
microplate reader (Molecular Devices, Basel, Switzerland).  169 
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 170 
Data analysis 171 
Data are presented as means ± SEM. Data for SCC, lactate, and LDH activity were log 172 
transformed (log10) to improve normality. Differences between LPS and control within each 173 
time point and differences between time points within one group were tested for significance 174 
(P < 0.05) by analysis of variance using a MIXED procedure of SAS (SAS Institute Inc., 175 
Cary, NC, USA, 2002-2008, Release 9.2). The model included time, treatment (LPS or 176 
control), the quarter within cow, and their interaction as fixed effects and the cow as repeated 177 
subject. For antibodies against bluetongue in milk OD values are presented in a descriptive 178 
way. 179 
 180 
Experiment 2: milk cell destruction 181 
Experimental design 182 
To investigate the effect of milk cell destruction on the lactate concentration and LDH activity 183 
in milk, eight quarter foremilk samples from 2 different cows were collected during one 184 
morning milking. Three aliquots of each milk sample were treated differently; one aliquot was 185 
frozen at -20 °C, a second was treated with ultrasound for 10 s at 100 watt (Branson Sonifier 186 
150), and the third served as a control without any treatment (stored in the refrigerator at 4°C). 187 
Catalytic activity of LDH and lactate concentration were then detected in milk serum, 188 
prepared as described previously, using the test kits LDH IFCC (Axon Lab AG, Baden, 189 
Switzerland) and Lactate PAP (bioMérieux, Marcy l`Etoile, France), respectively, in an 190 
autoanalyzer (COBAS MIRA, Roche Diagnostics, Switzerland) according to the 191 
manufacturer’s instructions.  192 
 193 
Data analysis 194 
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Data are presented as means ± SEM. For evaluation of changes of lactate and LDH through 195 
freezing and ultrasound, differences between treated and untreated samples were used. 196 
Differences between the treatments were tested for significance (P < 0.05) by analysis of 197 
variance using a MIXED procedure of SAS. The model included treatment as a fix effect and 198 
the sample as repeated subject.  199 
 200 
 201 
RESULTS 202 
Experiment 1: LPS induced mastitis 203 
Somatic Cell Count SCC started to increase in LPS treated quarters at 3 h post challenge 204 
(PC) and was significantly and continuously elevated from 4h PC until the end of the 205 
experiment compared to control quarters (Figure 1A). Control quarter SCC was significantly 206 
elevated only at 2 h PC when compared with 0 h.  207 
Lactate The lactate concentration in milk of LPS treated and control quarters (Figure 1B) was 208 
increased at 3 h PC (P < 0.0001 and P < 0.05, resp.) and reached concentrations similar to 209 
those observed in blood plasma (>1mM) by 6h PC, reaching a maximum at 7h PC. This 210 
increase in lactate was greater in LPS treated quarters as compared to control quarters 211 
(P<0.05). In two cows the lactate concentrations in milk of LPS treated quarters exceeded the 212 
values of those in blood. In the blood plasma, lactate concentration was higher at 2 h PC as 213 
compared to the concentration at 0 h (P < 0.05) and continued to increase steadily until the 214 
end of the experiment at 8 h PC.  215 
BHBA In 25 out of 90 milk samples BHBA concentrations were below the detection (Figure 216 
1C). In such cases half of the detection limit (0.05 mmol/L) was then used as a value for 217 
mathematical and statistical calculations. Significantly higher BHBA concentrations were 218 
identified in LPS quarters compared to control quarters from 3 h PC and continued to increase 219 
until the end of the experiment. Control quarter BHBA concentration did not change. The 220 
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BHBA blood concentration was not analyzed because it was controlled via a BHBA clamp 221 
infusion. At 0 h the BHBA concentration in blood plasma was 16 fold higher (P < 0.05) than 222 
in the milk. During the experiment this ratio diminished to a 3 fold difference at 8 h PC, but 223 
did not reach the blood plasma concentrations during the experiment.  224 
LDH The LDH activity in milk of LPS treated quarters (Figure 1D) was significantly higher 225 
at 3 h PC compared to control quarters and remained elevated until the end of the experiment, 226 
but did not reach blood concentrations. The activity of LDH in blood plasma and milk from 227 
control quarters did not change throughout the experiment. At t = 0 h the blood/milk LDH 228 
ratio was 29:1 decreasing during the experiment to be 3:1 at 8 h PC.  229 
IgG1 and IgG2  From 3 until 8 h PC IgG1 and IgG2 concentrations in milk of LPS treated 230 
quarters were significantly higher compared to control quarters (Figure 1E, Figure 1F). No 231 
changes in IgG1 and IgG2 concentrations in blood plasma and milk of control quarters could 232 
be detected throughout the experiment. The blood:milk IgG1 and IgG2 ratios were 77:1 and 233 
554:1, respectively, before LPS challenge. At 8 h PC the blood:milk IgG1 and IgG2 ratios 234 
diminished to 17:1 and 21:1, respectively. In addition, the ratio of IgG1:IgG2 in blood plasma 235 
and milk of treated and control quarters was calculated throughout the experiment (Figure 2). 236 
At t=0 h the ratio in milk from both treated and control quarters was approximately 4 while in 237 
blood the ratio was 0.48. In the blood plasma the ratio IgG1:IgG2 was 1.0:2.1 and did not 238 
change throughout the experiment. In the milk of the LPS treated quarter, the ratio started to 239 
decrease at 2 h, and reached the level of blood plasma at 3 h PC which was maintained until 240 
the end of experiment.  241 
Anti-bluetongue virus antibodies The non-quantitative test indicated that all examined milk 242 
samples were positive for anti-bluetongue virus antibodies (cut-off OD value for a positive 243 
result was 0.38). The OD values between 0 and 2 h PC ranged from 0.89 to 1.46 in control 244 
quarters and from 0.87 to 1.49 in LPS challenged quarters. Between 3 and 8 h PC the OD 245 
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values remained ranged still from 0.92 to 1.46 in control quarters but from 1.17 to 1.74 in LPS 246 
challenged quarters.  247 
 248 
Experiment 2: milk cell destruction 249 
Freezing and thawing and ultrasound treatment significantly increased the catalytic activity of 250 
LDH in milk by 44 and 50%, respectively. Freezing and thawing and ultrasound treatment 251 
had no effect on lactate concentrations in milk. (Figure 3) 252 
 253 
 254 
DISCUSSION 255 
In the present study changes in various blood and milk components were quantified during the 256 
early phase of a LPS induced mastitis. The observed increase in SCC in response to 257 
intramammary LPS challenge has been shown before (Baumert et al., 2009; Wellnitz et al., 258 
2011). The slight increase of SCC in the 2 first hours in all quarters was also expected and 259 
regularly observed after milking (Wellnitz et al., 2011). Coinciding with the infiltration of 260 
PMN, the blood milk barrier is expected to become leaky allowing blood constituents to enter 261 
the lumen (Burton & Erskine, 2003) or, as has been shown for lactose, exit the lumen and 262 
enter the circulation (Bruckmaier et al., 2004).  263 
The hypothesis that increased passage of blood constituents into milk occurs during mammary 264 
inflammation was supported by the present study. The increasing BHBA in milk after LPS 265 
challenge must have been blood derived because it occurred only in animals which received a 266 
BHBA infusion to keep blood BHBA concentrations constantly elevated throughout the 267 
experiment.  In cows with normal BHBA blood concentrations the concentration in milk 268 
remained below the detection limit for both LPS-treated and control quarters (0.1 mmol/L; 269 
data not shown). The accumulation of BHBA in milk of LPS-treated quarters suggests that 270 
LPS-induced mastitis causes a loss of the blood milk barrier integrity (Bannerman et al., 271 
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2004) and allows the BHBA molecules to pass through the barrier and to accumulate in milk. 272 
These results are in agreement with Nielsen et al. (2005) who found higher BHBA milk 273 
concentrations in diseased quarters compared to healthy quarters. The other investigated 274 
parameters lactate, LDH, and immunoglobulins started to increase at the same time after LPS 275 
challenge as BHBA which indicated that also these factors do at least in part originate from 276 
blood. 277 
Experiment 2 showed that milk cell disruption (by freezing or by ultrasound) leads to 278 
increased LDH activity in milk in agreement with earlier studies (Lipperheide et al., 1995; 279 
Kato et al., 1989) whereas lactate did not significantly change. Milk LDH activity was 280 
thought to originate from the blood and to be a suitable indicator of increased permeability of 281 
the blood milk barrier (Symons and Wright, 1974). In experiment 1 blood:milk LDH ratio 282 
decreased in response to LPS challenge in a similar manner to that observed for BHBA, yet 283 
milk concentrations did not reach those observed in blood within the experimental period. 284 
This is possibly due to the large difference in the molecular weights (140 KDa vs 104). Our 285 
current finding suggests that the origin of LDH in milk may be attributable to both soluble 286 
LDH from blood as well as disrupted leukocytes (Kato et al., 1989) and epithelial cells (Bogin 287 
et al., 1977; Zank and Schlatter, 1998).  288 
Lactate is known to increase in milk during mastitis (Davis et al., 2004). However, the origin 289 
of the lactate remained unclear. Our data demonstrated that lactate concentrations increase 290 
also in blood in response to intramammary LPS administration. Intravenous LPS 291 
administration has been shown to increase blood lactate concentrations in cows (Giri et al., 292 
1990). In the present study lactate concentration in milk of control quarters increased slightly 293 
but concomitantly with blood lactate concentration.  This is in contrast to SCC, BHBA, LDH, 294 
IgG1, IgG2, and anti-bluetongue virus antibodies which remained relatively stable in blood. 295 
This underlines the suggestion that the majority of lactate in healthy quarters originates from 296 
blood. 297 
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Lactate concentrations in milk of LPS-treated quarters increased to comparable levels to those 298 
in blood plasma (at 6 h PC), and, surprisingly, in two cows the concentrations of lactate in 299 
milk of LPS treated quarters exceeded the concentrations of lactate in blood. This is in 300 
contrast to the concentration of BHBA and LDH which was always higher in blood than in 301 
milk. This observation may be explained by additional lactate production and release during 302 
anaerobic metabolism by milk and epithelial cells in the gland (Silanikove et al., 2011; Mayer 303 
et al., 1988) whereas the results of experiment 2 showed that the lactate produced by cells in 304 
the milk appears to be released from these cells directly after synthesis. In addition, the small 305 
size of the lactate molecule (90Da) as compared to the other investigated constituents may 306 
allow for increased transfer from blood into milk. The existence of a specific transmembrane 307 
transport mechanism for lactate via aquaporins is likely since aquaporins transport lactate 308 
(Conde et al., 2010), and aquaporins are present in the bovine mammary gland (Mobasheri et 309 
al., 2011).  310 
In the present study IgG1 was the predominant IgG antibody subclass in milk before LPS 311 
challenge which is in agreement with earlier studies (Guidry et al., 1980; Butler, 1983). It is 312 
likely that the specific transport mechanism for IgG1 which is prevalent prepartum colostrum 313 
formation, remains weakly expressed during lactation. Both IgG1 and IgG2 increased 314 
simultaneously three hours after intramammary LPS challenge and the IgG1:IgG2 ratio 315 
reached a similar milk ratio to that observed in blood. IgG2 is considered to be the main 316 
opsonic antibody for neutrophil phagocytosis and is, therefore, most important for mammary 317 
immune defense against mastitis pathogens (Hill et al., 1983; Leitner et al., 2000). Both IgG1 318 
and IgG2 milk concentrations increased 3 h PC, along with SCC, BHBA, LDH, and lactate, 319 
indicating an unspecific transfer through the opening of the blood milk barrier. 320 
The results of the used ELISA for the detection of antibodies against blue tongue virus in milk 321 
can be interpreted solely as positive, doubtful, or negative according to the manufacturer.  322 
However, the higher OD values measured in milk of LPS challenged quarters after 3 h PC 323 
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indicate an increase of antibodies against bluetongue virus. Thus, a non-specific accumulation 324 
of various antibodies in the mammary gland during mastitis is likely. Obviously, during the 325 
alteration of the blood milk barrier, antibodies regardless of specificity, are able to pass the 326 
blood milk barrier. This is in agreement with Charlier et al. (2006) who found higher 327 
Ostertagia ostertagi antibody levels in milk of experimentally infected quarters. They 328 
described that an acute mastitis causes a flow of specific and non-specific antibodies from 329 
blood into milk. These finding could be important to understand the effectiveness of 330 
vaccinations against mastitis pathogens. 331 
 332 
 333 
CONCLUSIONS 334 
In conclusion, all investigated parameters appear to be blood derived and their increase in 335 
milk occurs in parallel with the increase of SCC. The integrity of the blood milk barrier is 336 
reduced during the early phase of LPS-induced mastitis. This allows various blood 337 
constituents to pass through the blood milk barrier to milk which may or may not support the 338 
mammary immune response. Intramammary LPS infusion also induces a systemic immune 339 
reaction shown by our evidence of an increase of blood lactate concentration that affects the 340 
lactate in milk of control quarters. The increase of some specific IgG in milk during 341 
mammary immune response may not be supportive for the mammary immune system, and is 342 
at least partially just a result of reduced integrity of the blood-milk barrier. However, these 343 
results show that the degree to which the blood milk barrier integrity is compromised by a 344 
mastitis pathogen influence milk composition and content of blood components.  The combat 345 
against mastitis pathogens may be improved by the alteration of the blood-milk barrier 346 
especially if specific antibodies are present in the blood. 347 
 348 
 349 
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Legend of the figures 
Figure 1  Milk somatic cell count (SCC, A), lactate (B), β-hydroxybutyrate (BHBA, C), 
lactate dehydrogenase (LDH, D), immunoglobulin G1 (IgG1, E), and 
immunoglobulin G2 (IgG2, F) concentrations, in milk of control quarters (●), 
LPS challenged quarters () and in the blood plasma (■) of 5 cows. * indicates a 
significant (P < 0.05) difference between LPS and control quarters within each 
time point. a,b,c,d,e : different letters indicate significant differences) between 
time points within control quarters; A,B,C,D,E within LPS challenged quarters; 
no letters indicate no differences between time points 
Figure 2 IgG1: IgG2 ratios in blood plasma (■) and milk of control quarters (●) and LPS 
challenged () quarters. * indicates a significant (P < 0.05) difference between 
LPS and control quarters within each time point. a,b,c: different letters indicate 
significant differences between time points within LPS treated quarters; no 
letters indicate no differences between time points (control quarters and blood 
plasma) 
Figure 3     Lactate concentration (A) and LDH activity (B) after different treatments (control, 
-20 °C, and ultrasound) of quarter foremilk samples (n=8). * indicates a 
significant difference (P < 0.05) between freezing or ultrasound treatment and 
control.  
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